Search Within

Chongrui Xu

Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (8)
  4. Weinberg Fellows (8)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  6. GSK Faculty (7)

More Groups

People
  1. Bob Li (8)
  2. Michael Offin (7)
  3. Charles Rudin (6)
  4. Pedram Razavi (6)
  5. Alexander Drilon (5)
  6. Maria Arcila (5)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (3)
  5. 2018 (2)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Discovery (1)
  3. JCO Precision Oncology (1)
  4. Journal of Thoracic Disease (1)
  5. Journal of Thoracic Oncology (1)
  6. Lung Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Elsevier Ireland Ltd. (1)
  5. Nature Publishing Group (1)
  6. Pioneer Bioscience Publishing Company (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
    Journal Article

    Mondaca, S.; Lebow, E. S.; Namakydoust, A.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Offin, M.; Tu, H. Y.; Murciano-Goroff, Y.; Xu, C.; more...
    Lung Cancer (2021)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
    Meeting Abstract

    Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers
    Meeting Abstract

    Offin, M.; Xu, C.; Jain, H.; Makhnin, A.; Hayes, S. A.; Plodkowski, A. J.; Halpenny, D.; Rudin, C. M.; Kris, M. G.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Liquid biopsy guided precision therapy for lung cancers
    Journal Article

    Xu, C.; Offin, M.; Paik, P. K.; Li, B. T.
    Journal of Thoracic Disease (2018)

    Fulltext@MSK | Save